Home
/
BIOTRICITY INC.
/
Financials
/
Quarterly
BIOTRICITY INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that BIOTRICITY INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2019
Dec 31, 2018
$117.6K
Feb 19, 2019
Q2
2019
Sep 30, 2018
$84.8K
Nov 14, 2018
Q1
2019
Jun 30, 2018
$17.7K
Aug 14, 2018
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Dec 31, 2025
$3.99M
Feb 11, 2026
Q2
2026
Sep 30, 2025
$3.89M
Nov 14, 2025
Q1
2026
Jun 30, 2025
$3.87M
Aug 14, 2025
Q3
2026
Dec 31, 2024
$3.62M
Feb 11, 2026
Q2
2026
Sep 30, 2024
$3.27M
Nov 14, 2025
Q1
2026
Jun 30, 2024
$3.20M
Aug 14, 2025
Q3
2025
Dec 31, 2023
$2.97M
Feb 20, 2025
Q2
2025
Sep 30, 2023
$2.89M
Nov 14, 2024
Q1
2025
Jun 30, 2023
$3.02M
Aug 19, 2024
Q3
2024
Dec 31, 2022
$2.46M
Feb 20, 2024
Q2
2024
Sep 30, 2022
$2.38M
Nov 14, 2023
Q1
2024
Jun 30, 2022
$2.06M
Aug 14, 2023
Q3
2023
Dec 31, 2021
$1.93M
Feb 14, 2023
Q2
2023
Sep 30, 2021
$1.81M
Nov 14, 2022
Q1
2023
Jun 30, 2021
$1.76M
Aug 15, 2022
Q3
2022
Dec 31, 2020
$1.00M
Feb 14, 2022
Q2
2021
Sep 30, 2020
$744.6K
Nov 4, 2021
Q1
2022
Jun 30, 2020
$451.9K
Aug 17, 2021
Q3
2021
Dec 31, 2019
$381.9K
Feb 16, 2021
Q2
2021
Sep 30, 2019
$345.9K
Nov 13, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Dec 31, 2025
($717.1K)
Feb 11, 2026
Q2
2026
Sep 30, 2025
($690.9K)
Nov 14, 2025
Q1
2026
Jun 30, 2025
($672.0K)
Aug 14, 2025
Q3
2026
Dec 31, 2024
($1.23M)
Feb 11, 2026
Q2
2026
Sep 30, 2024
($1.56M)
Nov 14, 2025
Q1
2026
Jun 30, 2024
($3.69M)
Aug 14, 2025
Q3
2025
Dec 31, 2023
($2.81M)
Feb 20, 2025
Q2
2025
Sep 30, 2023
($3.69M)
Nov 14, 2024
Q1
2025
Jun 30, 2023
($3.41M)
Aug 19, 2024
Q3
2024
Dec 31, 2022
($4.52M)
Feb 20, 2024
Q2
2024
Sep 30, 2022
($4.69M)
Nov 14, 2023
Q1
2024
Jun 30, 2022
($4.78M)
Aug 14, 2023
Q3
2023
Dec 31, 2021
($7.11M)
Feb 14, 2023
Q2
2023
Sep 30, 2021
($10.75M)
Nov 14, 2022
Q1
2023
Jun 30, 2021
($5.66M)
Aug 15, 2022
Q3
2022
Dec 31, 2020
($3.90M)
Feb 14, 2022
Q2
2021
Sep 30, 2020
($2.96M)
Nov 13, 2020
Q1
2022
Jun 30, 2020
($3.16M)
Aug 17, 2021
Q3
2021
Dec 31, 2019
($2.37M)
Feb 16, 2021
Q2
2021
Sep 30, 2019
($2.01M)
Nov 13, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Dec 31, 2025
$440.9K
Feb 11, 2026
Q2
2026
Sep 30, 2025
$273.8K
Nov 14, 2025
Q1
2026
Jun 30, 2025
$281.9K
Aug 14, 2025
Q3
2026
Dec 31, 2024
($169.0K)
Feb 11, 2026
Q2
2026
Sep 30, 2024
($307.7K)
Nov 14, 2025
Q1
2026
Jun 30, 2024
($1.12M)
Aug 14, 2025
Q3
2025
Dec 31, 2023
($1.28M)
Feb 20, 2025
Q2
2025
Sep 30, 2023
($2.19M)
Nov 14, 2024
Q1
2025
Jun 30, 2023
($2.32M)
Aug 19, 2024
Q3
2024
Dec 31, 2022
($3.84M)
Feb 20, 2024
Q2
2024
Sep 30, 2022
($4.03M)
Nov 14, 2023
Q1
2024
Jun 30, 2022
($4.09M)
Aug 14, 2023
Q3
2023
Dec 31, 2021
($4.74M)
Feb 14, 2023